Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Non-oral treatment with ivermectin for disseminated strongyloidiasis.

Fusco DN, Downs JA, Satlin MJ, Pahuja M, Ramos L, Barie PS, Fleckenstein L, Murray HW.

Am J Trop Med Hyg. 2010 Oct;83(4):879-83. doi: 10.4269/ajtmh.2010.10-0258.

2.

Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.

Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR.

Clin Infect Dis. 2005 Jul 1;41(1):e5-8. Epub 2005 May 11.

PMID:
15937753
3.

[Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].

Manrique-Rodríguez S, Martín-Rabadán P, Díaz-Cámara M, Fernández-Llamazares CM.

Med Clin (Barc). 2016 Apr 15;146(8):376-7. doi: 10.1016/j.medcli.2015.10.008. Epub 2015 Dec 2. Spanish. No abstract available.

PMID:
26654554
4.

Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.

Turner SA, Maclean JD, Fleckenstein L, Greenaway C.

Am J Trop Med Hyg. 2005 Nov;73(5):911-4.

5.

Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.

Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W.

Am J Trop Med Hyg. 2008 Dec;79(6):853-5.

6.

Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.

Salluh JI, Feres GA, Velasco E, Holanda GS, Toscano L, Soares M.

Intensive Care Med. 2005 Sep;31(9):1292. Epub 2005 Jul 22. No abstract available.

PMID:
16041520
7.

Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.

Bogoch II, Khan K, Abrams H, Nott C, Leung E, Fleckenstein L, Keystone JS.

Am J Trop Med Hyg. 2015 Jul;93(1):94-6. doi: 10.4269/ajtmh.15-0077. Epub 2015 Apr 27.

8.

Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.

Moura EB, Maia Mde O, Ghazi M, Amorim FF, Pinhati HM.

Braz J Infect Dis. 2012 Sep-Oct;16(5):479-81. doi: 10.1016/j.bjid.2012.08.008. Epub 2012 Sep 10.

9.

Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.

Arch EL, Schaefer JT, Dahiya A.

Dermatol Online J. 2008 Dec 15;14(12):6.

10.

Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report.

Grein JD, Mathisen GE, Donovan S, Fleckenstein L.

Scand J Infect Dis. 2010 Mar;42(3):234-6. doi: 10.3109/00365540903443165.

PMID:
20085425
11.

[Fulminant strongyloidiasis successfully treated by subcutaneous ivermectin: an autopsy case].

Takashima N, Yazawa S, Ishihara A, Sugimoto S, Shiomi K, Hiromatsu K, Nakazato M.

Rinsho Shinkeigaku. 2008 Jan;48(1):30-5. Japanese.

PMID:
18386629
12.

Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.

Lichtenberger P, Rosa-Cunha I, Morris M, Nishida S, Akpinar E, Gaitan J, Tzakis A, Doblecki-Lewis S.

Transpl Infect Dis. 2009 Apr;11(2):137-42. doi: 10.1111/j.1399-3062.2008.00358.x. Epub 2008 Dec 17. Review.

PMID:
19144097
13.

Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS.

Torres JR, Isturiz R, Murillo J, Guzman M, Contreras R.

Clin Infect Dis. 1993 Nov;17(5):900-2.

PMID:
8286637
14.

Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.

Donadello K, Cristallini S, Taccone FS, Lorent S, Vincent JL, de Backer D, Jacobs F.

Int J Antimicrob Agents. 2013 Dec;42(6):580-3. doi: 10.1016/j.ijantimicag.2013.07.015. Epub 2013 Sep 7.

PMID:
24269075
15.

Parenteral ivermectin in Strongyloides hyperinfection.

Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J.

Lancet. 2000 Jan 1;355(9197):43-4.

PMID:
10615895
16.

Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome.

Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR.

Am J Trop Med Hyg. 2003 Apr;68(4):453-5.

17.

Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient.

Briasoulis A, Psevdos G.

South Med J. 2011 Jan;104(1):72-3. doi: 10.1097/SMJ.0b013e3181f61647. No abstract available.

PMID:
21119560
18.

Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.

Hays R, Esterman A, McDermott R.

PLoS Negl Trop Dis. 2015 Aug 21;9(8):e0003976. doi: 10.1371/journal.pntd.0003976. eCollection 2015 Aug 21.

19.

[Treatment of experimental infection by Strongyloides venezuelensis in rats, with the use of injectable ivermectin and levamisole].

Campos R, Pinto PL, Amato Neto V, Matsubara L, Miyamoto A, de Carvalho SA, Takiguti CK, Moreira AA.

Rev Inst Med Trop Sao Paulo. 1989 Jan-Feb;31(1):48-52. Portuguese.

PMID:
2814204
20.

Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis.

Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sánchez-Sánchez P, Matogo-Oyana J, Rodríguez-Calabuig D.

Expert Opin Pharmacother. 2004 Dec;5(12):2615-9. Review.

PMID:
15571478

Supplemental Content

Support Center